SCHEMBL7526246

SCHEMBL7526246

O=P(Cl)(N(c1ccccc1)c1ccccc1)N(c1ccccc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.48
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
ALDH1A1 P00352 7/20 0.39
NPSR1 Q6W5P4 2/20 0.39
ALOX15 P16050 1/20 0.39
KCNA5 P22460 1/20 0.38
TDP1 Q9NUW8 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
KDM4E B2RXH2 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
MAPT P10636 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPC1 O15118 2/20 0.37
POLB P06746 2/20 0.37
RAB9A P51151 2/20 0.37
CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27651298 0.84 HTT (0.48) HTTKMT2AMEN1ALDH1A1NPSR1
SCHEMBL5892 0.80 HTT (0.44) HTTKMT2AMEN1ALDH1A1NPSR1
SCHEMBL8370301 0.78 HTT (0.59) HTTKMT2AMEN1ALDH1A1NPSR1
SCHEMBL7528709 0.74 HTT (0.48) HTTKMT2AMEN1ALDH1A1NPSR1
SCHEMBL96680 0.74 HTT (0.48) HTTKMT2AMEN1ALDH1A1NPSR1
SCHEMBL8530739 0.74 MEN1 (0.48) HTTKMT2AMEN1ALDH1A1NPSR1
SCHEMBL2309806 0.74 MEN1 (0.48) HTTKMT2AMEN1ALDH1A1NPSR1
SCHEMBL18889454 0.74 HTT (0.54) HTTKMT2AMEN1ALDH1A1NPSR1
SCHEMBL10568061 0.72 MEN1 (0.58) HTTKMT2AMEN1ALDH1A1ALOX15
SCHEMBL12150822 0.72 HTT (0.46) HTTKMT2AMEN1ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020107391-A1 Process for the synthesis of an endothelin receptor antagonist FREY LISA F (US) 2002-08-08 US claimed
CN-119930689-A Synthetic method of bio-based phosphorus-nitrogen synergistic flame retardant and high-flame-retardance polymer composition prepared by using same 浙江嘉民新材料有限公司 2025-05-06 CN disclosed
US-20020107391-A1 Process for the synthesis of an endothelin receptor antagonist FREY LISA F (US) 2002-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107391-A1 Process for the synthesis of an endothelin receptor antagonist EDNRA, EDNRB, AGTR2 HTT 2931/4885KMT2A 2890/4885MEN1 568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.